Blood markers may reveal who is at risk from severe abdominal infections

NCT ID NCT07689266

Completed Knowledge-focused Sponsor: Istanbul Training and Research Hospital Source: ClinicalTrials.gov ↗

First seen Jul 08, 2026 · Last updated Jul 09, 2026 · Updated 1 time

Summary

This study looks at whether certain immune checkpoint molecules found in the blood can help predict how serious an intra-abdominal infection is and the risk of death. Researchers will measure 10 different molecules in 75 patients with these infections. The goal is to better understand the body's immune response during severe infections, which could eventually lead to improved monitoring or treatment strategies.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

What this could lead to: If certain immune molecules are strongly linked to worse outcomes, this could point toward new ways to monitor or treat severe infections.
What could go wrong: This is a small observational study, not a treatment trial. It can only show associations, not cause and effect, and results may not apply to all patients.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for INTRA ABDOMINAL INFECTIONS are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

intestinal perforation Intraabdominal Infections Sepsis

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

INTRA ABDOMINAL INFECTIONS

Contacts and locations

Show contact details

Locations

Istanbul Training and Research Hospital

Istanbul, 34098, Turkey (Türkiye)

More trials for these conditions

Other studies related to the condition(s) this trial covers.